z-logo
open-access-imgOpen Access
Chemical systems biology reveals mechanisms of glucocorticoid receptor signaling
Author(s) -
Nelson E. Bruno,
Jerome C. Nwachukwu,
Sathish Srinivasan,
Charles C. Nettles,
Tina Izard,
Zhuang Jin,
J. Nowak,
Michael D. Cameron,
Siddaraju V. Boregowda,
Donald G. Phinney,
Olivier Elemento,
Xu Liu,
Eric A. Ortlund,
René Houtman,
Diana A. Stavreva,
Gordon L. Hager,
Theodore M. Kamenecka,
D.J. Kojetin,
K.W. Nettles
Publication year - 2021
Publication title -
nature chemical biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.412
H-Index - 216
eISSN - 1552-4469
pISSN - 1552-4450
DOI - 10.1038/s41589-020-00719-w
Subject(s) - allosteric regulation , glucocorticoid receptor , ligand (biochemistry) , biology , receptor , glucocorticoid , signal transduction , chemical biology , anabolism , microbiology and biotechnology , biochemistry , endocrinology
Glucocorticoids display remarkable anti-inflammatory activity, but their use is limited by on-target adverse effects including insulin resistance and skeletal muscle atrophy. We used a chemical systems biology approach, ligand class analysis, to examine ligands designed to modulate glucocorticoid receptor activity through distinct structural mechanisms. These ligands displayed diverse activity profiles, providing the variance required to identify target genes and coregulator interactions that were highly predictive of their effects on myocyte glucose disposal and protein balance. Their anti-inflammatory effects were linked to glucose disposal but not muscle atrophy. This approach also predicted selective modulation in vivo, identifying compounds that were muscle-sparing or anabolic for protein balance and mitochondrial potential. Ligand class analysis defined the mechanistic links between the ligand-receptor interface and ligand-driven physiological outcomes, a general approach that can be applied to any ligand-regulated allosteric signaling system.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here